The recent advent of multidetector computed tomography angiography (CTA) has greatly improved image quality and may allow more precise evaluation of coronary stenosis and plaque morphology. 1, 2 Previous CTA studies introduced the concept of noninvasive detection and characterization of coronary atherosclerotic lesions in patients with AMI and stable angina pectoris (SAP) 3 and identified differences in lesion morphology and plaque composition between culprit lesions in patients with acute coronary syndrome (ACS) and stable lesions in patients with ACS or SAP. 4 Recently,
Motoyama et al. demonstrated that CT characteristics of culprit lesions in ACS included
positive remodeling (PR) and low-attenuation plaques (LAP) 5 and that patients with these 2 plaque characteristics on CTA were at a higher risk of ACS developing during follow-up when compared with patients having lesions without these characteristics. 6 We therefore hypothesized that positively remodeled plaques with LAP in non-culprit lesions, favoring a propensity to rapidly progress to a culprit lesion or rupture, might be more frequently observed in AMI patients within the proximal third of the major epicardial coronary arteries. To investigate this hypothesis, we examined whether 64-slice CTA can noninvasively assess the spatial distribution, morphology, and composition of non-culprit lesions in patients with AMI in comparison with stable lesions in patients with SAP.
Methods
We studied a prospective but nonconsecutive series of 226 patients who underwent 64-slice CTA from September 2006 to December 2007. The study population consisted of 64 patients with AMI and 162 symptomatic patients with suspected coronary artery disease (CAD) who underwent stress myocardial perfusion imaging (MPI). In these 162
patients, stress MPI was positive in 72 patients and negative in 90 patients. AMI was defined as follows: 1) chest pain >30 minutes in duration with presentation within 12 hours after the onset of symptoms; 2) ST-segment elevation >0.1 mV within 2 contiguous electrocardiograph leads; 3) elevated creatine kinase-MB isoenzymes within 12 hours of chest pain. AMI patients underwent 64-slice CTA within 2 week after successful primary stenting. SAP was defined as no change in frequency, duration, or intensity of chest pain within 4 weeks in patients in sinus heart rhythm and without previous myocardial infarction, previous PCI or coronary bypass surgery, and unstable angina.
Of the 226 patients, 16 patients (4 in the AMI group, 5 in the SAP with abnormal MPI group, and 7 in the SAP with normal MPI group) were excluded from analysis due to image artifacts that made assessment of the entire coronary anatomy impossible on CTA images. The remaining 210 patients (AMI group, n = 60; SAP with abnormal MPI group, n = 67; SAP with normal MPI group, n = 83) represent the population of this study.
Written informed consent was obtained from all patients, and the study protocol was approved by our institutional review board.
Scanning was performed with a 64-slice CT scanner (Aquilion 64; Toshiba Medical Systems Corporation, Otawara, Japan). According to a previous published protocol, 2 images were acquired with 64 × 0.5-mm slice collimation, gantry rotation speed of 400 ms/rotation, Coronary atherosclerotic plaque was visually classified as follows: 1) non-calcified plaque was defined as any discernible structure that could be assigned to the coronary artery wall, with CT attenuation below that of the contrast-enhanced coronary lumen but above that of the surrounding connective tissue/epicardial fat 7, 8 ; 2) calcified plaque was defined as any structure with CT attenuation of >130 HU that could be visualized separately from the contrast-enhanced coronary lumen (either because it was embedded within non-calcified plaque or because its density was above that of the contrast-enhanced lumen). Spotty calcification was defined when <3 mm in size on curved multi-planar reformation and 1-sided on cross-sectional images 5 ; 3) mixed plaque was defined as plaque with non-calcified and calcified elements present; 4) LAP was defined as plaque with low CT density (<30 HU). 6 The remodeling index (RI) was calculated by dividing the lesion diameter at the plaque site of maximum luminal narrowing by the reference diameter (proximal to the lesion in a normal-appearing vessel segment). PR was defined as a RI of >1.10. We used the coronary map modified from the Bypass Angioplasty Revascularization Investigation (BARI). 9 Proximal segments of coronary plaque location included #1 proximal right coronary artery (RCA), #12
proximal left anterior descending artery (LAD), and #18 proximal left circumflex (LC).
Middle segments included #2 mid RCA, #13 Mid LAD, #15 diagonal 1 branches, #19
mid LC, and #20 obtuse marginal 1. Distal segments included #3 distal RCA, #4
posterior descending, #6 posterior lateral segment, #14 distal LAD, #16 diagonal 2 branches, #19a distal LCx, and #21 obtuse marginal 2.
Tl-201 SPECT was performed within 1 week of the CTA. Beta-blockers, calcium channel blockers, and nitrates were discontinued for 24-48 hours before the test.
Adenosine was administered intravenously to all patients at 0.14 mg/kg/min for 6 minutes, and a dose of 111 MBq of Tl-201 was injected 3 minutes into the infusion. ECG and blood pressure were monitored before, throughout, and after the infusion. The initial image was obtained in the supine position at 5 minutes after the Tl-201 injection, and a delayed image was obtained 4 hours later.
SPECT was performed using a double-detector system (PICKER PRISM 2000XP;
Shimadzu Corporation, Kyoto, Japan) equipped with a low-energy, high-resolution collimator according to a previous published protocol. 2 SPECT images were assessed using a 17-segment model. 10 Stress and delayed images were independently analyzed by 2 nuclear medicine physicians who were blinded to the CTA data. Visual grading was defined as normal (no perfusion defects) or abnormal (stress perfusion defects with redistribution).
Hypertension was defined as blood pressure at rest ≥140/90 mmHg or use of antihypertensive medication. Hyperlipidemia was defined as total fasting serum cholesterol ≥200 mg/dl or serum triglycerides ≥150 mg/dl or use of antihyperlipidemic 
Results
Baseline clinical characteristics of the patients are summarized in Table 1 (p <0.01). In the AMI group, the number of PR and LAP was significantly higher in patients with metabolic syndrome than in those without, whereas there was no difference in the total number of plaques between these two groups ( Figure 3 ).
Spatial distribution of non-culprit coronary plaques in AMI patients on CTA images is shown in Figure 4 . In the LAD and LCx coronary arteries, non-calcified, calcified, and mixed plaques were more frequently distributed in the proximal segments, whereas there were no differences in distribution of non-calcified, calcified, and mixed plaques in the RCA. PR and LAP were more frequently distributed in the proximal segments of the LAD, whereas there were no differences in distribution of PR and LAP in the RCA and 
Discussion
The major important findings of the present study are as follows. First, CT-based plaque burden is higher in AMI patients and SAP patients with abnormal MPI than in SAP patients with normal MPI. Non-culprit coronary plaque appearance mimics that of culprit lesions. Second, in the AMI patients, the number of noncalcified plaques with low CT density and positive remodeling was significantly higher in patients with metabolic syndrome than in those without the syndrome, and these plaques were more frequently distributed in the proximal segments of the LAD. Therefore, 64-slice CTA may noninvasively provide promising information on preventive strategies by facilitating identification of coronary plaque morphology and zones at high risk for future events in AMI patients.
Approximately 6% of PCI patients will have clinical plaque progression requiring non-target lesion PCI by 1 year, and greater coronary artery disease burden confers a significantly higher risk for clinical plaque progression. 13 With its higher X-ray output and faster tube rotation, 64-slice CTA results in high-quality, motion-free, and isotropic image quality. 1 In the present study, we showed that on CTA images, a significantly greater number of coronary plaques in non-culprit lesions is observed in AMI patients than in SAP patients with normal MPI. Non-calcified, mixed, and PR and LAP were more significantly observed in AMI patients than in SAP patients. Leber et al. found that non-calcified plaques contribute to a higher degree to total plaque burden in AMI than in SAP. 3 In addition, 64-slice CTA enables the visualization of lipid cores and spotty calcifications that are frequently associated with plaque ruptures. 7 Positive remodeling and lipid cores are associated with plaque vulnerability in both histopathologic 14 and intravascular ultrasound (IVUS) studies. 15, 16 Patients demonstrating positively remodeled coronary segments with LAP on CTA are at a higher risk of ACS developing over time. 6 The present study suggests that all 3 major coronary arteries in patients with AMI are extensively diseased and have multiple plaques that could potentially cause another occurrence of ACS, although the natural course of this plaque development and disruption has not yet been clearly established.
Recent studies have demonstrated that metabolic syndrome is associated with an increasing risk of cardiovascular disease. 17 Furthermore, IVUS study has shown that metabolic syndrome is associated with lipid-rich plaques that contribute to the increasing risk of plaque vulnerability. 18 In the present study, within the AMI group, the number of PR and LAP was significantly higher in patients with metabolic syndrome than in those without the syndrome. This finding might explain the mechanism of metabolic syndrome contributing to the increased risk of cardiovascular events.
A previous study examined the geographical distribution of occlusive thromboses throughout the coronary tree and showed that such occlusions are clustered within the proximal portions of the major epicardial arteries. 19 In the present study, we observed culprit lesions and PR and LAP of non-culprit lesions in the proximal LAD of AMI patients more frequently than in other sites on CTA. The use of optical coherence tomography (OCT) revealed thin-capped fibroatheromas (TCFAs) in the proximal left coronary artery more frequently than in other sites. 20 The frequency of PR and LAP we observed is very similar to that of the TCFAs reported in the previous OCT study. We have shown that CTA can noninvasively reveal the PR and LAP in non-culprit lesions favoring a propensity to rapidly progress to a culprit lesion or rupture.
The largest prognostic study with thallium-201 SPECT showed a cardiac mortality rate of 0.42%/y in patients with normal scans and 2.1%/y in patients with abnormal scans. 21 However it is not clear how many of these patients had vulnerable coronary plaques leading to ACS and cardiac events. In the present study, we showed that the number of coronary plaques in non-culprit lesions is observed significantly less frequently in SAP patients with normal MPI than in AMI patients. Specifically, calcified plaques were more significantly observed in SAP patients with abnormal MPI than in AMI patients. The prevalence of CAD in SAP patients with normal MPI was also small, in concordance with 14 published reports comprising more than 12000 patients that showed normal stress SPECT 99m
Tc-sestamibi images to be associated with an average annual hard event rate of 0.6%. The current study has some limitations. First, radiation dose levels to the patient are relatively high when stress MPI and CTA are combined. It is expected that radiation exposure will be significantly reduced with the use of a modified protocol that includes ECG-pulsing. Second, the threshold of 30 HU for the LAP was limited as the CT density of non-calcified plaques depends on the image quality and intraluminal contrast attenuation, and no correlation to IVUS was performed in the present study. 
